The purpose of this study is to 1) evaluate the safety and efficacy of two doses of bupropion SR (150mg/day and 300mg/day) when compared to placebo, as an aid to smoking cessation in adolescents and 2) to examine which factors, such as medication adherence, nicotine dependence, and motivation to quit, affect treatment outcome.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
University of Arizona
Tucson, Arizona, United States
Biochemically verified 7 day point prevalence abstinence from smoking.
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.